Increased nitric oxide production in patients with Behcet's disease: Is it a new activity marker?

被引:87
作者
Evereklioglu, C
Turkoz, Y
Er, H
Inaloz, HS
Ozbek, E
Cekmen, M
机构
[1] Inonu Hosp Med Fac, Res Hosp, Dept Ophthalmol, Malatya, Turkey
[2] Inonu Hosp Med Fac, Res Hosp, Dept Biochem, Malatya, Turkey
[3] Gaziantep Univ Med Fac, Res Hosp, Dept Ophthalmol, Gazlantep, Turkey
[4] Gaziantep Univ Med Fac, Res Hosp, Dept Dermatol, Gazlantep, Turkey
[5] Gaziantep Univ Med Fac, Res Hosp, Dept Urol, Gazlantep, Turkey
[6] Gaziantep Univ Med Fac, Res Hosp, Dept Biochem, Gazlantep, Turkey
关键词
D O I
10.1067/mjd.2002.118338
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background. The origin of Behcet's disease (BD) is unclear. One of the prominent features of BD is vasculitis and thrombosis as a result of endothelial dysfunction. Because nitric oxide (NO) is synthesized by endothelium, we considered it as an interesting target of investigation in BD. Objective: Our purpose was to define the level of NO in the serum of patients with BD and its relation with disease activity. Methods: As an indicator for NO, serum total nitrite levels (end product of NO) were measured by Griess reaction in 52 consecutive patients with BD and compared with 32 age- and sex-matched healthy staff volunteers. Serum NO levels of active and inactive patients were compared. Results: The overall serum nitrite levels in patients with BD (40.25 +/- 10.51 mumol/L) were significantly higher (P < .001) than those in healthy volunteers (25.09 +/- 5.33 mumol/L). The difference in serum total nitrite levels among patients with active BD (46.74 +/- 10.62 mumol/L) and inactive BD (33.24 +/- 3.73 mumol/L) was significant (P < .001). Significant differences were observed in serum nitrite between patients in the inactive period of BD and the control group (P < .001). Conclusion: Increased NO production might be responsible for the inflammatory process of BD, NO seems to be related to disease activity.
引用
收藏
页码:50 / 54
页数:5
相关论文
共 22 条
[1]  
Behçet H, 1937, DERMATOL WOCHENSCHR, V105, P1152
[2]   INTERNATIONAL-UVEITIS-STUDY-GROUP RECOMMENDATIONS FOR THE EVALUATION OF INTRAOCULAR INFLAMMATORY DISEASE [J].
BLOCHMICHEL, E ;
NUSSENBLATT, RB .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1987, 103 (02) :234-235
[3]   BEHCETS DISEASE - REPORT OF 41 CASES AND A REVIEW OF LITERATURE [J].
CHAJEK, T ;
FAINARU, M .
MEDICINE, 1975, 54 (03) :179-196
[4]   Nitric oxide [J].
Farrell, AJ ;
Blake, DR .
ANNALS OF THE RHEUMATIC DISEASES, 1996, 55 (01) :7-20
[5]   Behcet's disease and complex aphthosis [J].
Ghate, JV ;
Jorizzo, JL .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (01) :1-18
[6]  
Granger DL, 1996, METHOD ENZYMOL, V268, P142
[7]  
Hirohata T, 1975, Hawaii Med J, V34, P244
[8]   ENDOTHELIAL-CELL PRODUCTION OF NITROGEN-OXIDES IN RESPONSE TO INTERFERON-GAMMA IN COMBINATION WITH TUMOR-NECROSIS-FACTOR, INTERLEUKIN-1, OR ENDOTOXIN [J].
KILBOURN, RG ;
BELLONI, P .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (09) :772-776
[9]   PATHOLOGIC FEATURES OF BEHCETS SYNDROME - A REVIEW OF JAPANESE AUTOPSY REGISTRY DATA [J].
LAKHANPAL, S ;
TANI, K ;
LIE, JT ;
KATOH, K ;
ISHIGATSUBO, Y ;
OHOKUBO, T .
HUMAN PATHOLOGY, 1985, 16 (08) :790-795
[10]  
LINCOLN J, 1997, NITRIC OXIDE HLTH DI, P22